Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Bioscience - Landmark is Scopus-indexed (Q2, CiteScore 5.7), WoS SCIE, DOAJ. Published by IMR Press Limited.
Checked against the index lists dated .
ISSN 2768-6698Verify ISSN ↗2768-6701Verify ISSN ↗
Publisher: IMR Press Limited
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (all) | 63 / 223 | 71st | Q2 |
| Immunology and Microbiology (all) | 20 / 63 | 69th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q2, CiteScore 5.7.
Frontiers in Bioscience - Landmark is Q2 in Biochemistry, Genetics and Molecular Biology (all) (rank 63 of 223) and Q2 in Immunology and Microbiology (all) (rank 20 of 63), by CiteScore 2025.
Frontiers in Bioscience - Landmark is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.7, which places it in quartile Q2 at the 71st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.915, quartile Q1, with an H-index of 174.
The publisher lists an article processing charge of about US$2,500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Frontiers in Bioscience - Landmark is published by IMR Press Limited. Its print ISSN is 2768-6698 and its online ISSN is 2768-6701.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Frontiers in Bioscience - Landmark has an h-index of 43 and a 2-year mean of 4.61 citations per paper (OpenAlex). Its Scopus CiteScore is 5.7, quartile Q2. On 2-year citations it ranks #45 of 221 Scopus journals in Biochemistry, Genetics and Molecular Biology (all).
Frontiers in Bioscience - Landmark published 380 papers in 2025; its busiest recent year was 2024 with 430. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from China (63.4%), United States (6.2%) and Russia (5.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (3.1 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.